原发性甲状旁腺功能亢进

AACE/AAES Task Force on Primary Hyperparathyroidism. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract. 2005 Jan-Feb;11(1):49-54.

• 全文
• 摘要

Greenspan BS, Dillehay G, Intenzo C, et al. SNM practice guideline for parathyroid scintigraphy 4.0. J Nucl Med Technol. 2012 Jun;40(2):111-8.

• 全文
• 摘要

Udelsman R, Donovan PI. Minimally invasive parathyroid surgery. World J Surg. 2004 Dec;28(12):1224-6.

• 摘要

1.  Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151:959-968.

• 全文
• 摘要

2.  Khan AA, Hanley DA, Rizzoli R, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017;28:1-19.

• 全文
• 摘要

3.  Fang SH, Lal G. Parathyroid cancer. Endocr Pract. 2011;17(suppl 1):36-43.

• 摘要

4.  Bilezikian JP, Potts JT Jr, Fuleihan G el-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab. 2002 Dec;87(12):5353-61.

• 全文
• 摘要

5.  McDow AD, Sippel RS. Should symptoms be considered an indication for parathyroidectomy in primary hyperparathyroidism? Clin Med Insights Endocrinol Diabetes. 2018 Jun 27;11:1179551418785135.

• 全文
• 摘要

6.  Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001 Dec;86(12):5658-71.

• 摘要

7.  Lundgren E, Hagström EG, Lundin J, et al. Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago. World J Surg. 2002 Aug;26(8):931-6.

• 摘要

8.  Wermers RA, Khosla S, Atkinson EJ, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res. 2006 Jan;21(1):171-7.

• 摘要

9.  Yeh MW, Ituarte PH, Zhou HC, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013 Mar;98(3):1122-9.

• 摘要

10.  Griebeler ML, Kearns AE, Ryu E, et al. Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010). Bone. 2015 Apr;73:1-7.

• 摘要

11.  Boonstra CE, Jackson CE. Serum calcium survey for hyperparathyroidism: results in 50,000 clinic patients. Am J Clin Pathol. 1971 May;55(5):523-6.

• 摘要

12.  Silverberg SJ, Bilezikian JP. The diagnosis and management of asymptomatic primary hyperparathyroidism. Nat Clin Pract Endocrinol Metab. 2006 Sep;2(9):494-503.

• 摘要

13.  Arnold A, Staunton CE, Kim HG, et al. Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med. 1988 Mar 17;318(11):658-62.

• 摘要

14.  Farford B, Presutti RJ, Moraghan TJ. Nonsurgical management of primary hyperparathyroidism. Mayo Clin Proc. 2007 Mar;82(3):351-5. [Erratum in: Mayo Clin Proc. 2007 Jul;82(7):890.]

• 摘要

15.  Thakker RV. Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol Cell Endocrinol. 2014 Apr 5;386(1-2):2-15.

• 全文
• 摘要

16.  Chen JD, Morrison C, Zhang C, et al. Hyperparathyroidism-jaw tumour syndrome. J Intern Med. 2003 Jun;253(6):634-42.

• 摘要

17.  Marx SJ. Etiologies of parathyroid gland dysfunction in primary hyperparathyroidism. J Bone Miner Res. 1991 Oct;6(suppl 2):S19-24.

• 摘要

18.  Vanderwalde LH, Haigh PI. Surgical approach to the patient with familial hyperparathyroidism. Curr Treat Options Oncol. 2006 Jul;7(4):326-33.

• 摘要

19.  Hundley JC, Woodrum DT, Saunders BD, et al. Revisiting lithium-associated hyperparathyroidism in the era of intraoperative parathyroid hormone monitoring. Surgery. 2005 Dec;138(6):1027-31.

• 摘要

20.  Taniegra ED. Hyperparathyroidism. Am Fam Physician. 2004 Jan 15;69(2):333-9.

• 全文
• 摘要

21.  Jorde R, Waterloo K, Saleh F, et al. Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels: The Tromso study. J Neurol. 2006 Apr;253(4):464-70.

• 摘要

22.  AACE/AAES Task Force on Primary Hyperparathyroidism. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract. 2005 Jan-Feb;11(1):49-54.

• 全文
• 摘要

23.  Awad SS, Miskulin J, Thompson N. Parathyroid adenomas versus four-gland hyperplasia as the cause of primary hyperparathyroidism in patients with prolonged lithium therapy. World J Surg. 2003 Apr;27(4):486-8.

• 摘要

24.  Teh BT, Farnebo F, Kristoffersson U, et al. Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. J Clin Endocrinol Metab. 1996 Dec;81(12):4204-11.

• 摘要

25.  Simonds WF, James-Newton LA, Agarwal SK, et al. Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine (Baltimore). 2002 Jan;81(1):1-26.

• 摘要

26.  Tisell LE, Carlsson S, Fjalling M, et al. Hyperparathyroidism subsequent to neck irradiation. Risk factors. Cancer. 1985 Oct 1;56(7):1529-33.

• 摘要

27.  Sheldon DG, Lee FT, Neil NJ, Ryan JA Jr. Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg. 2002 Sep;137(9):1022-6; discussion 1026-8.

• 全文
• 摘要

28.  Pasieka JL, Parsons LL. Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg. 1998 Jun;22(6):513-8; discussion 518-9.

• 摘要

29.  Pasieka JL, Parsons L, Jones J. The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study. Surgery. 2009 Dec;146(6):1006-13.

• 摘要

30.  Ambrogini E, Cetani F, Cianferotti L, et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab. 2007 Aug;92(8):3114-21.

• 摘要

31.  Perrier ND, Balachandran D, Wefel JS, et al. Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism. Surgery. 2009 Dec;146(6):1116-22.

• 摘要

32.  Morris GS, Grubbs EG, Hearon CM, et al. Parathyroidectomy improves functional capacity in "asymptomatic" older patients with primary hyperparathyroidism: a randomized controlled trial. Ann Surg. 2010 May;251(5):832-7.

• 摘要

33.  Rodgers SE, Perrier ND. Parathyroid carcinoma. Curr Opin Oncol. 2006 Jan;18(1):16-22.

• 摘要

34.  Weaver S, Doherty DB, Jimenez C, et al. Peer-reviewed, evidence-based analysis of vitamin D and primary hyperparathyroidism. World J Surg. 2009 Nov;33(11):2292-302.

• 摘要

35.  Hindié E, Ugur O, Fuster D, et al; Parathyroid Task Group of the EANM. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1201-16.

• 全文
• 摘要

36.  Scott-Coombes DM, Rees J, Jones G, et al. Is unilateral neck surgery feasible in patients with sporadic primary hyperparathyroidism and double negative localisation? World J Surg. 2017 Jun;41(6):1494-9.

• 摘要

37.  Cheung K, Wang TS, Farrokhyar F, et al. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol. 2012 Feb;19(2):577-83.

• 摘要

38.  Treglia G, Trimboli P, Huellner M, et al. Imaging in primary hyperparathyroidism: focus on the evidence-based diagnostic performance of different methods. Minerva Endocrinol. 2018 Jun;43(2):133-43.

• 摘要

39.  Greenspan BS, Dillehay G, Intenzo C, et al. SNM practice guideline for parathyroid scintigraphy 4.0. J Nucl Med Technol. 2012 Jun;40(2):111-8.

• 全文
• 摘要

40.  Treglia G, Sadeghi R, Schalin-Jäntti C, et al. Detection rate of (99m) Tc-MIBI single photon emission computed tomography (SPECT)/CT in preoperative planning for patients with primary hyperparathyroidism: A meta-analysis. Head Neck. 2016 Apr;38(suppl 1):E2159-72.

• 摘要

41.  Lavely WC, Goetze S, Friedman KP, et al. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase 99mTc-Sestamibi parathyroid scintigraphy. J Nucl Med. 2007 Jul;48(7):1084-9. [Erratum in: J Nucl Med. 2007 Sep;48(9):1430.]

• 摘要

42.  Ulivieri FM, Silva BC, Sardanelli F, et al. Utility of the trabecular bone score (TBS) in secondary osteoporosis. Endocrine. 2014 Nov;47(2):435-48.

• 摘要

43.  Odvina CV, Sakhaee K, Heller HJ, et al. Biochemical characterization of primary hyperparathyroidism with and without kidney stones. Urol Res. 2007 Jun;35(3):123-8.

• 摘要

44.  Silverberg SJ, Shane E, Jacobs TP, et al. Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med. 1990 Sep;89(3):327-34.

• 摘要

45.  Monchik JM, Gorgun E. Normocalcemic hyperparathyroidism in patients with osteoporosis. Surgery. 2004 Dec;136(6):1242-6.

• 摘要

46.  Prager G, Abela C, Niederle B. Metabolic complications of primary hyperparathyroidism. In: Clark OH, Duh QY, Kebebew E, eds. Textbook of endocrine surgery. 2nd ed. Philadelphia, PA: Elsevier Saunders; 2005:402-12.

47.  McAllion SJ, Paterson CR. Psychiatric morbidity in primary hyperparathyroidism. Postgrad Med J. 1989 Sep;65(767):628-31.

• 摘要

48.  Joborn C, Hetta J, Johansson H, et al. Psychiatric morbidity in primary hyperparathyroidism. World J Surg. 1988 Aug;12(4):476-81.

• 摘要

49.  Wilhelm SM, Lee J, Prinz RA. Major depression due to primary hyperparathyroidism: a frequent and correctable disorder. Am Surg. 2004 Feb;70(2):175-9.

• 摘要

50.  Mittendorf EA, Wefel JS, Meyers CA, et al. Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism. Endocr Pract. 2007 Jul-Aug;13(4):338-44.

• 摘要

51.  Turken SA, Cafferty M, Silverberg SJ, et al. Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism. Am J Med. 1989 Nov;87(5):553-7.

• 摘要

52.  Best CAE, Krishnan R, Malvankar-Mehta MS, et al. Echocardiogram changes following parathyroidectomy for primary hyperparathyroidism: a systematic review and meta-analysis. Medicine (Baltimore). 2017 Oct;96(43):e7255.

• 全文
• 摘要

53.  Pepe J, Cipriani C, Curione M, et al. Reduction of arrhythmias in primary hyperparathyroidism, by parathyroidectomy, evaluated with 24-h ECG monitoring. Eur J Endocrinol. 2018 Aug;179(2):117-24.

• 摘要

54.  Kepez A, Yasar M, Sunbul M, et al. Evaluation of left ventricular functions in patients with primary hyperparathyroidism: is there any effect of parathyroidectomy? Wien Klin Wochenschr. 2017 May;129(9-10):329-36.

• 摘要

55.  Pepe J, Cipriani C, Sonato C, et al. Cardiovascular manifestations of primary hyperparathyroidism: a narrative review. Eur J Endocrinol. 2017 Dec;177(6):R297-308.

• 摘要

56.  Brown RC, Aston JP, Weeks I, et al. Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay. J Clin Endocrinol Metab. 1987 Sep;65(3):407-14.

• 摘要

57.  Kluijfhout WP, Pasternak JD, Beninato T, et al. Diagnostic performance of computed tomography for parathyroid adenoma localization; a systematic review and meta-analysis. Eur J Radiol. 2017 Mar;88:117-28.

• 摘要

58.  Walker MD, Bilezikian JP. Primary hyperparathyroidism: recent advances. Curr Opin Rheumatol. 2018 Jul;30(4):427-39.

• 摘要

59.  Udelsman R, Åkerström G, Biagini C, et al. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014 Oct;99(10):3595-606.

• 摘要

60.  Lundstam K, Heck A, Godang K, et al. Effect of surgery versus observation: skeletal 5-year outcomes in a randomized trial of patients with primary HPT (the SIPH study). J Bone Miner Res. 2017 Sep;32(9):1907-14.

• 摘要

61.  Zhang L, Liu X, Li H. Long-term skeletal outcomes of primary hyperparathyroidism patients after treatment with parathyroidectomy: a systematic review and meta-analysis. Horm Metab Res. 2018 Mar;50(3):242-9.

• 摘要

62.  Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014 Oct;99(10):3561-9.

• 摘要

63.  Udelsman R, Donovan PI. Minimally invasive parathyroid surgery. World J Surg. 2004 Dec;28(12):1224-6.

• 摘要

64.  Singh Ospina NM, Rodriguez-Gutierrez R, Maraka S, et al. Outcomes of parathyroidectomy in patients with primary hyperparathyroidism: a systematic review and meta-analysis. World J Surg. 2016 Oct;40(10):2359-77.

• 摘要

65.  Gracie D, Hussain SS. Use of minimally invasive parathyroidectomy techniques in sporadic primary hyperparathyroidism: systematic review. J Laryngol Otol. 2012 Mar;126(3):221-7.

• 摘要

66.  Yen TW, Wang TS. Subtotal parathyroidectomy for primary hyperparathyroidism. Endocr Pract. 2011 Mar-Apr;17(suppl 1):7-12.

• 摘要

67.  Khan AA, Bilezikian JP, Kung AW, et al. Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2004 Jul;89(7):3319-25.

• 全文
• 摘要

68.  Leere JS, Karmisholt J, Robaczyk M, et al. Contemporary medical management of primary hyperparathyroidism: a systematic review. Front Endocrinol (Lausanne). 2017 Apr 20;8:79.

• 全文
• 摘要

69.  Peacock M, Bilezikian JP, Klassen PS, et al. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2005 Jan;90(1):135-41.

• 全文
• 摘要

70.  Ibraheem K, Toraih EA, Haddad AB, et al. Selective parathyroid venous sampling in primary hyperparathyroidism: a systematic review and meta-analysis. Laryngoscope. 2018 May 14 [Epub ahead of print].

• 摘要

71.  Jinih M, O'Connell E, O'Leary DP, et al. Focused versus bilateral parathyroid exploration for primary hyperparathyroidism: a systematic review and meta-analysis. Ann Surg Oncol. 2017 Jul;24(7):1924-34.

• 摘要

72.  Harrison BJ, Triponez F. adjuncts in surgery for primary hyperparathyroidism. Langenbecks Arch Surg. 2009 Sep;394(5):799-809.

73.  Sokoll LJ, Wians FH Jr, Remaley AT. Rapid intraoperative immunoassay of parathyroid hormone and other hormones: a new paradigm for point-of-care testing. Clin Chem. 2004 Jul;50(7):1126-35.

• 全文
• 摘要

74.  Allendorf J, DiGorgi M, Spanknebel K, et al. 1112 consecutive bilateral neck explorations for primary hyperparathyroidism. World J Surg. 2007 Nov;31(11):2075-80.

• 摘要

75.  Abdulla AG, Ituarte PH, Harari A, et al. Trends in the frequency and quality of parathyroid surgery: analysis of 17,082 cases over 10 years. Ann Surg. 2015 Apr;261(4):746-50.

• 摘要

76.  Yu N, Donnan PT, Leese GP. A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf). 2011 Aug;75(2):169-76.

• 全文
• 摘要

77.  Yu N, Leese GP, Donnan PT. What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf). 2013 Jul;79(1):27-34.

• 摘要

78.  Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68.

• 全文
• 摘要

79.  Marcocci C, Bollerslev J, Khan AA, et al. Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2014 Oct;99(10):3607-18.

• 摘要

80.  Stein EM, Dempster DW, Udesky J, et al. Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism. Bone. 2011 Mar 1;48(3):557-61.

• 摘要

81.  Kantorovich V, Gacad MA, Seeger LL, et al. Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism. J Clin Endocrinol Metab. 2000 Oct;85(10):3541-3.

• 摘要

82.  Bollerslev J, Marcocci C, Sosa M, et al. Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. Eur J Endocrinol. 2011 Dec;165(6):851-64.

• 摘要

83.  Loh HH, Lim LL, Yee A, et al. Effect of vitamin D replacement in primary hyperparathyroidism with concurrent vitamin D deficiency: a systematic review and meta-analysis. Minerva Endocrinol. 2017 Mar 14 [Epub ahead of print].

• 摘要

84.  Grey A, Lucas J, Horne A, et al. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrinol Metab. 2005 Apr;90(4):2122-6.

• 摘要

85.  Harman CR, Grant CS, Hay ID, et al. Indications, technique, and efficacy of alcohol injection of enlarged parathyroid glands in patients with primary hyperparathyroidism. Surgery. 1998 Dec;124(6):1011-9.

• 摘要

86.  Singh Ospina N, Thompson GB, Lee RA, et al. Safety and efficacy of percutaneous parathyroid ethanol ablation in patients with recurrent primary hyperparathyroidism and multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2015 Jan;100(1):E87-90.

• 摘要

87.  Alherabi AZ, Marglani OA, Alfiky MG, et al. Percutaneous ultrasound-guided alcohol ablation of solitary parathyroid adenoma in a patient with primary hyperparathyroidism. Am J Otolaryngol. 2015 Sep-Oct;36(5):701-3.

• 摘要

88.  Arora A, Cunningham A, Chawdhary G, et al. Clinical applications of Telerobotic ENT-Head and Neck surgery. Int J Surg. 2011;9(4):277-84.

• 摘要

89.  Bearelly S, Prendes BL, Wang SJ, et al. Transoral robotic-assisted surgical excision of a retropharyngeal parathyroid adenoma: A case report. Head Neck. 2015 Nov;37(11):E150-2.

• 摘要

90.  Kovatcheva R, Vlahov J, Stoinov J, et al. US-guided high-intensity focused ultrasound as a promising non-invasive method for treatment of primary hyperparathyroidism. Eur Radiol. 2014 Sep;24(9):2052-8.

• 摘要

91.  Imbus JR, Randle RW, Pitt SC, et al. Machine learning to identify multigland disease in primary hyperparathyroidism. J Surg Res. 2017 Nov;219:173-9.

• 全文
• 摘要

92.  Silverberg SJ, Shane E, Jacobs TP, et al. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med. 1999 Oct 21;341(17):1249-55. [Erratum in: N Engl J Med. 2000 Jan 13;342(2):144.]

• 全文
• 摘要

93.  Grant CS, Thompson G, Farley D, et al. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg. 2005 May;140(5):472-8.

• 全文
• 摘要

94.  Burkey SH, van Heerden JA, Thompson GB, et al. Reexploration for symptomatic hematomas after cervical exploration. Surgery. 2001 Dec;130(6):914-20.

• 摘要

95.  Chester MW, Stewart MG. Arytenoid adduction combined with medialization thyroplasty: an evidence-based review. Otolaryngol Head Neck Surg. 2003 Oct;129(4):305-10.

• 摘要

96.  Vasher M, Goodman A, Politz D, et al. Postoperative calcium requirements in 6,000 patients undergoing outpatient parathyroidectomy: easily avoiding symptomatic hypocalcemia. J Am Coll Surg. 2010 Jul;211(1):49-54.

• 摘要

97.  Marcus R. The role of estrogens and related compounds in the management of primary hyperparathyroidism. J Bone Miner Res. 2002 Nov;17(suppl 2):N146-9.

• 摘要

98.  Zanchetta JR, Bogado CE. Raloxifene reverses bone loss in postmenopausal women with mild asymptomatic primary hyperparathyroidism. J Bone Miner Res. 2001 Jan;16(1):189-90.

• 摘要

99.  Pallan S, Khan A. Primary hyperparathyroidism: update on presentation, diagnosis, and management in primary care. Can Fam Physician. 2011 Feb;57(2):184-9.

• 全文
• 摘要

100.  Sankaran S, Gamble G, Bolland M, et al. Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis. J Clin Endocrinol Metab. 2010 Apr;95(4):1653-62.

• 全文
• 摘要

101.  Marcocci C, Brandi ML, Scillitani A, et al. Italian Society of Endocrinology consensus statement: definition, evaluation and management of patients with mild primary hyperparathyroidism. J Endocrinol Invest. 2015 May;38(5):577-93.

• 摘要

102.  Guerrero MA, Wray CJ, Kee SS, et al. Minimally invasive parathyroidectomy complicated by pneumothoraces: a report of 4 cases. J Surg Educ. 2007 Mar-Apr;64(2):101-7.

• 摘要

103.  de la Plaza Llamas R, Ramia Ángel JM, Arteaga Peralta V, et al. Elevated parathyroid hormone levels after successful parathyroidectomy for primary hyperparathyroidism: a clinical review. Eur Arch Otorhinolaryngol. 2018 Mar;275(3):659-69.

• 摘要

104.  Guerin C, Paladino NC, Lowery A, et al. Persistent and recurrent hyperparathyroidism. Updates Surg. 2017 Jun;69(2):161-9.

• 摘要